Some remarkable successes in the clinic give Russell—and his commercial and pharmaceutical partners, including Regeneron—the belief that this can become an increasingly important aspect of cancer therapy . . .
The post The Life Oncolytic, with Stephen Russell appeared first on GEN – Genetic Engineering and Biotechnology News.
